Terumo Corporation TUO.F Stock
Terumo Corporation Price Chart
Terumo Corporation TUO.F Financial and Trading Overview
Terumo Corporation stock price | 16 EUR |
Previous Close | 29.8 EUR |
Open | 29.8 EUR |
Bid | 29.8 EUR x 40000 |
Ask | 30.6 EUR x 40000 |
Day's Range | 29.8 - 29.8 EUR |
52 Week Range | 24.2 - 34.6 EUR |
Volume | 204 EUR |
Avg. Volume | 5 EUR |
Market Cap | 21.95B EUR |
Beta (5Y Monthly) | 0.462835 |
PE Ratio (TTM) | 38.205128 |
EPS (TTM) | 0.4 EUR |
Forward Dividend & Yield | 0.3 (1.00%) |
Ex-Dividend Date | September 28, 2023 |
1y Target Est | N/A |
TUO.F Valuation Measures
Enterprise Value | 66.95B EUR |
Trailing P/E | 38.205128 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.026763171 |
Price/Book (mrq) | 0.019971235 |
Enterprise Value/Revenue | 0.082 |
Enterprise Value/EBITDA | 0.347 |
Trading Information
Terumo Corporation Stock Price History
Beta (5Y Monthly) | 0.462835 |
52-Week Change | 11.11% |
S&P500 52-Week Change | 20.43% |
52 Week High | 34.6 EUR |
52 Week Low | 24.2 EUR |
50-Day Moving Average | 27.05 EUR |
200-Day Moving Average | 27.68 EUR |
TUO.F Share Statistics
Avg. Volume (3 month) | 5 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 734.2M |
Float | 729.72M |
Short Ratio | N/A |
% Held by Insiders | 4.32% |
% Held by Institutions | 56.06% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 40 |
Trailing Annual Dividend Yield | 134.22% |
5 Year Average Dividend Yield | 87.00% |
Payout Ratio | 0.3194 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 10.89% |
Operating Margin (ttm) | 14.95% |
Gross Margin | 50.88% |
EBITDA Margin | 23.51% |
Management Effectiveness
Return on Assets (ttm) | 4.98% |
Return on Equity (ttm) | 8.41% |
Income Statement
Revenue (ttm) | 820.21B EUR |
Revenue Per Share (ttm) | 1092.72 EUR |
Quarterly Revenue Growth (yoy) | 12.50% |
Gross Profit (ttm) | 417.37B EUR |
EBITDA | 192.91B EUR |
Net Income Avi to Common (ttm) | 89.33B EUR |
Diluted EPS (ttm) | 0.78 |
Quarterly Earnings Growth (yoy) | 11.79% |
Balance Sheet
Total Cash (mrq) | 187.32B EUR |
Total Cash Per Share (mrq) | 251.57 EUR |
Total Debt (mrq) | 231.94B EUR |
Total Debt/Equity (mrq) | 20.88 EUR |
Current Ratio (mrq) | 2.805 |
Book Value Per Share (mrq) | 1492.146 |
Cash Flow Statement
Operating Cash Flow (ttm) | 117.54B EUR |
Levered Free Cash Flow (ttm) | 31.79B EUR |
Profile of Terumo Corporation
Country | Germany |
State | N/A |
City | Tokyo |
Address | 2-44-1, Hatagaya |
ZIP | 151-0072 |
Phone | 81 3 3374 8111 |
Website | https://www.terumo.co.jp |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
Q&A For Terumo Corporation Stock
What is a current TUO.F stock price?
Terumo Corporation TUO.F stock price today per share is 16 EUR.
How to purchase Terumo Corporation stock?
You can buy TUO.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Terumo Corporation?
The stock symbol or ticker of Terumo Corporation is TUO.F.
Which industry does the Terumo Corporation company belong to?
The Terumo Corporation industry is Medical Instruments & Supplies.
How many shares does Terumo Corporation have in circulation?
The max supply of Terumo Corporation shares is 1.48B.
What is Terumo Corporation Price to Earnings Ratio (PE Ratio)?
Terumo Corporation PE Ratio is 40.00000000 now.
What was Terumo Corporation earnings per share over the trailing 12 months (TTM)?
Terumo Corporation EPS is 0.4 EUR over the trailing 12 months.
Which sector does the Terumo Corporation company belong to?
The Terumo Corporation sector is Healthcare.